Advertising disclosure — We may earn a commission if you start care through some of these links, at no extra cost to you. How we're funded. Order reflects our editorial rubric and our commercial relationships; scores are ours alone.
Luna Fit
Peter MD review
A physician-prescribed telehealth brand (Miami, founded 2021) that puts GLP-1 care on the same account as TRT, ED, NAD+, sermorelin and hair loss — genuinely broad, but built for a general and largely male-first audience rather than PCOS or hormonal care specific to women.
- Semaglutide
- $149/mo (Level 1, new patients; $447 total for a 10-12 wk supply) or $139/mo (Level 2, returning; $834 total for an 8-12 wk supply) — compounded semaglutide + B12
- Tirzepatide
- $249/mo billed quarterly ($149 first month), 60mg dose
- Coverage
- Restrictions vary by treatment — several states excluded
- Brand-name
- Compounded only
The Luna Fit scorecard
Peter MD scored on our six women's-health factors. See the methodology.
What we like
- One of the widest catalogs in this ranking: TRT, ED, weight loss, GLP-1, men's hair loss and NAD+ all live under a single account
- Physician-prescribed rather than a form-only handoff
- Both GLP-1 molecules disclosed with real per-product pricing, not a single vague headline figure
- Serves both men and women — unusual for a program this TRT-forward
The caveats
- Price varies meaningfully by tier and product — semaglutide alone has two published rates (new vs. returning patient) whose totals don't cleanly reduce to one monthly number
- Tirzepatide is billed quarterly with a first-month teaser rate ($149) against a $249/mo standing charge — budget for the standing rate, not the number in the hero
- State restrictions vary by treatment and are broader than the customer-facing pages disclose — the affiliate program's own listing excludes several more states (AL, AR, CA, ID, IA, KY, LA, MA, MI, NC, SC, TX depending on the product) than the marketing pages mention
- No PCOS, perimenopause or menopause program — the ranking's women's-hormone lens isn't this brand's focus, and its broader catalog leans toward men's health verticals
- No published lab or monitoring cadence in the pricing pages we reviewed
- Customer reviews are mixed
The bottom line
Best for: Someone who wants tirzepatide or compounded semaglutide alongside TRT, NAD+, sermorelin or hair-loss care on one login, and doesn't need a women's-hormone-specialized program to get it. A physician-prescribed telehealth brand (Miami, founded 2021) that puts GLP-1 care on the same account as TRT, ED, NAD+, sermorelin and hair loss — genuinely broad, but built for a general and largely male-first audience rather than PCOS or hormonal care specific to women.
Ranked #53 of 80 providers we reviewed for women — see our #1 pick, CoreAge Rx, for comparison. Nationwide access is where Peter MD scores lowest, at 65/100. If that is your sticking point, start with the full field we rank against Peter MD.
Others in Peter MD's score range
The providers scoring closest to Peter MD on the same six factors. One of those comparisons is written out in full: Peter MD against CoreAge Rx, factor by factor, 21 points apart on the Luna Fit Score. Directly below Peter MD sits Oak at #54 with 72/100 — see our ranked shortlist of Oak alternatives if that is the band you are shopping in.
See all 80 providers we've reviewed for women — ranked on the same rubric, with scores and pricing side by side.
Pricing, states and verification reflect Peter MD's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on Peter MD's site. Not medical advice; see our disclosure.